A new study finds that Americans in rural and micropolitan areas have far lower access to neurological care and subspecialty multiple sclerosis care than those in metropolitan regions.Read More
We’re building a new hub for neurological care on our main campus equipped with ideal spaces and technologies for delivering the best care possible today while developing the care of tomorrow.
A study finds that women are underrepresented among physician authors of neurology practice guidelines. Both clinical care and women neurologists’ professional development may suffer as a result.
This landmark prospective investigation aims to study up to 200,000 healthy individuals over 20 years to identify brain disease biomarkers and targets for preventing and curing neurological disorders.
Our Neurological Institute has rolled out a distinctive framework of four career tracks for professional staff. We share the rationale, the details and the response so far.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A survey of neurosurgeons shows that nearly two-thirds of respondents have witnessed sexual harassment at work or during training and over half of respondents have experienced it personally.
Changes around stroke center designation, rural stroke care, telestroke services and reimbursement are highlights of the American Academy of Neurology’s first statement update in 10 years.
Gregory Nemunaitis, MD, brings to Cleveland Clinic 30 years of expertise in spinal cord injury (SCI) care and research — as well as a passion to educate everyone about SCI rehab however he can.
An NIA grant will help Cleveland Clinic Lou Ruvo Center for Brain Health establish the Nevada exploratory Alzheimer’s Disease Research Center to reduce disparities in dementia care in rural settings.
The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic is designed to screen and advise women in their 30s to 60s who have no symptoms but are concerned about their risk.
A large national database study has confirmed that the short-term benefits of swift administration of thrombolytic therapy continue out to at least one year.